Nanobiotechnology and Nanomedicine Companies
Showing results 1 - 9 of 9 for companies in Israel:
Aposense is a clinical stage molecular imaging and drug development company, focused on the introduction of novel agents based on the identification and targeting of cells undergoing apoptosis (programmed cell death).
A drug development company that has developed an innovative, nanotechnology-based system called NEOWATER. NEOWATER is a commercially available broad enabling platform upon which research, diagnostics, biotech and pharma companies can obtain disruptive price-performance results and overcome current technology barriers with an elegant implementation.
Nano Retina, Inc. is developing an ultra small, easy to implant, artificial retina designed to restore sight.
Nanolymf Ltd. is a subsidiary of Shizim Ltd. with the mission to meet the challenges of enhancing the bioavailability of highly lipophilic drugs, by introducing the market with a novel controlled release double layered nanoencapsulation delivery system.
Nicast Ltd. develops superior medical devices from electrospun nanofabric for a wide range of clinical applications. Electrospun nanofabric is a biomaterial made of ultra-thin polymer fibers, with properties that mimic those of human tissues and organs.
NST is a clinical stage molecular imaging and drug development company, focused on the introduction of novel agents (ApoSense - a small molecule 'Interfacial Nanoswitch') based on the identification and targeting of cells undergoing apoptosis.
Develops nano-encapsulation technology for delivery applications for nutraceuticals and drugs.
The company's technology involves the encapsulation, at room temperature, of active ingredients in micro- and nano-sized glass (silica) matrices as well as nanospheres utilizing a chemical process called sol-gel.
A drug delivery company developing enhanced and improved therapeutic medicines in several fields. Solubest is using advanced polymer formulations to prepare nanotransporters for drugs having delivery or compliance insufficiencies.
